| |
Active LN (n = 16)
|
Stable LN (n = 10)
|
AAV (n = 6)
|
IgAN (n = 9)
|
MCD/FSGS (MCD, n = 4; FSGS, n = 1)
|
HC (n = 8)
|
|---|
|
Age (years)
|
31 (23–45)
|
53 (31.75–61.25)
|
52 (45.5–59.5)
|
45 (35.5–57)
|
53 (40.5–62)
|
49.5 (40.5–55.5)
|
|
Female, n (%)
|
15 (93.75)
|
10 (100)
|
4 (66.67)
|
8 (88.89)
|
3 (60)
|
6 (75)
|
|
WBC count, × 103/mL
|
4.43 (3.32–6.54)
|
4.30 (3.67–4.89)
|
9.98 (6.89–15.37)
|
8.1 (7.36–8.35)
|
8.02 (6.28–10.01)
|
5.44 (4.56–7.77)
|
|
CRP, mg/L
|
0.15 (0.07–1.15)
|
0.05 (0.03–0.16)
|
2.21 (0.38–10.35)
|
0.03 (0.01–0.15)
|
0.04 (0.02–0.05)
|
0.02 (0.01–0.05)
|
|
Serum BUN, mg/dL
|
14.5 (12–18.75)
|
15.5 (12.25–22.25)
|
31 (21.75–58.75)
|
17 (14.5–27)
|
14 (11.5–23.5)
|
15 (11–16)
|
|
UPCR, mg/mg
|
2.93 (0.90–5.87)
|
0.21 (0.09–0.36)
|
2.16 (1.233–2.97)
|
1.6 (0.90–4.62)
|
9.55 (3.99–16.88)
|
0.05 (0.04–0.11)
|
|
Serum anti-dsDNA, IU/ml
|
512 (267.9–849.8)
|
6.7 (2–155.9)
|
N/A
|
N/A
|
N/A
|
N/A
|
|
C3, mg/dL
|
44.5 (39.5–59.75)
|
69.5 (47.75–84.75)
|
106.5 (93.75–112.3)
|
99 (85–124)
|
N/A
|
N/A
|
|
C4, mg/dL
|
8 (5.5–16)
|
10.5 (4.5–21)
|
25 (12.5–30.25)
|
28 (20.5–32.5)
|
N/A
|
N/A
|
- The data are presented as the median and interquartile range (IQR) or as number (percentage)
- Abbreviations: LN lupus nephritis, AAV ANCA-associated vasculitis, IgAN IgA nephropathy, MCD minimal change disease, FSGS focal segmental glomerulosclerosis, HC healthy control, WBC white blood cell, CRP C-reactive protein, BUN blood urea nitrogen, UPCR urine protein to creatinine ratio, dsDNA double-stranded DNA, C3 complement component 3, C4 complement component 4
